Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Human RIG-I Antiviral Deficiency Caused by a Dominant-Negative Variant Locked in a Signaling-Inactive State.

medRxiv : the preprint server for health sciences·2026

Same author

Sub-neutralizing concentrations of Zika virus IgM monoclonal antibodies reduce IgG-mediated antibody-dependent enhancement of infectivity.

bioRxiv : the preprint server for biology·2026

Same author

Structural heterogeneity of apolipoprotein B-100.

The FEBS journal·2026

Same author

Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies.

The Journal of experimental medicine·2025

Same author

CD81 is a receptor for equine arteritis virus (family: <i>Arteriviridae</i>).

mBio·2025

Same author

Convergence and divergence of B cell responses in two HIV-1 Env immunizations in Rhesus macaques.

Communications medicine·2025

Same journal

Lactate binds and inhibits the innate immune sensor STING to promote tumor immune evasion.

Immunity·2026

Same journal

Antibody binding geometry and affinity control inhibitory hFcγRIIB receptor signaling.

Immunity·2026

Same journal

The transcription factor Eomes drives a stemness program in CD4<sup>+</sup> T cells that promotes anti-tumor immunity in response to immunotherapy.

Immunity·2026

Same journal

Stem-like precursors of exhausted Th cells upheld by a Tox-Myb-Eomes transcriptional hierarchy propagate Th cell responses in chronic infection.

Immunity·2026

Same journal

Monocytic niches escape T cell surveillance and promote Mycobacterium tuberculosis persistence in lymph nodes.

Immunity·2026

Same journal

Analysis of West Nile disease convalescents identifies human monoclonal antibodies protective against West Nile and related orthoflaviviruses.

Immunity·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Oct 4, 2025

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

HCV neutralization goes elite.

Mattia Bonsignori¹, Joseph Marcotrigiano²

¹Translational Immunobiology Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

|February 9, 2022

Summary

This summary is machine-generated.

Developing a Hepatitis C virus (HCV) vaccine is crucial for eradication. Researchers identified potent neutralizing antibodies and a computational method to guide the design of effective immunogens for an HCV vaccine.

More Related Videos

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Related Experiment Videos

Last Updated: Oct 4, 2025

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Area of Science:

Virology
Immunology
Vaccine Development

Background:

Hepatitis C virus (HCV) infection poses a significant global health challenge.
A prophylactic vaccine is considered the most viable strategy for HCV eradication.
Identifying broadly neutralizing antibodies is key to vaccine design.

Purpose of the Study:

To identify elite neutralizers of Hepatitis C virus (HCV).
To isolate and characterize potent, broad neutralizing antibodies targeting the CD81-binding site.
To develop a computational approach for predicting antibody-escape mutations and guiding immunogen design.

Main Methods:

Analysis of HCV elite neutralizers.
Isolation and characterization of V_H1-69 B cell receptor antibodies.
Determination of shared antigen recognition modes.
Development of a computational model for predicting gain-of-function mutations.

Main Results:

Identification of elite neutralizers with potent and broad antibody responses against HCV.
Isolation of neutralizing antibodies targeting the CD81-binding site.
Discovery of a shared mode of antigen recognition among these antibodies.
Development of a predictive computational tool for antibody escape mutations.

Conclusions:

The identified antibodies and their recognition mode provide insights for rational HCV vaccine design.
The computational approach can inform the development of immunogens that elicit broadly neutralizing antibody responses.
This work advances the quest for a protective HCV vaccine.